Drugmakers Plan 2026 U.S. Price Increases on Over 350 Branded Medications Despite Political Pressure 
Google Accelerates AI Infrastructure With Ironwood TPU Expansion in 2026 
Australia’s Modern Gold Rush: Hobby Prospectors Flock to Victoria’s Golden Triangle 
Novo Nordisk and Eli Lilly Cut Obesity Drug Prices in China as Competition Intensifies 
Vanda Pharmaceuticals Wins FDA Approval for New Motion Sickness Drug After Four Decades 
Target Stock Rallies as Activist Interest Sparks Hopes for Strategic Change 
ByteDance Plans Massive AI Chip Spending Boost as Nvidia Demand Grows in China 
Citigroup to Exit Russia With Sale of AO Citibank to Renaissance Capital 
Bain Capital Moves to Acquire Majority Stake in Echo Marketing 
Disney Agrees to $10 Million Settlement Over Child Privacy Violations on YouTube 
Novo Nordisk and Eli Lilly Cut Obesity Drug Prices in China, Boosting Access to Wegovy and Mounjaro 
Samsung Signals Comeback With HBM4 Chips as AI Market Heats Up 
Elon Musk’s xAI Expands Supercomputer Infrastructure With Third Data Center to Boost AI Training Power 
Boeing Secures $8.6 Billion Pentagon Contract for F-15 Jets for Israel 
Royalty Pharma Stock Rises After Acquiring Full Evrysdi Royalty Rights from PTC Therapeutics 
Starlink Plans Satellite Orbit Reconfiguration in 2026 to Boost Space Safety 
Boeing Secures Major $2.7 Billion U.S. Military Contract for Apache Helicopter Support 
ALLEN, Texas, March 13, 2017 -- Atrion Corporation (NASDAQ:ATRI) today announced the election of Preston G. Athey as a director effective immediately. Mr. Athey recently retired after an extraordinary 38 year career with T. Rowe Price Associates. In 1991, he began managing the firm's Small-Cap Value Fund. Under his tutelage, fund assets grew from $45 million to $10 billion. Mr. Athey holds a BA degree from Yale University and an MBA degree from Stanford University. Mr. Athey brings a wealth of financial and operational experience, and will be another strong voice for our stockholders.
Atrion Corporation develops and manufactures products primarily for medical applications. The Company’s website is www.atrioncorp.com.
Contact: Jeffery Strickland Vice President and Chief Financial Officer (972) 390-9800
